Print page Close print preview
Logo Going International

3rd RAS/MAPK Pathway Targeted Drug Discovery Summit

Evvnt Promotion / evvnt
22.02.2022 - 24.02.2022  Online, USA
Time: 9:00 AM - 3:30 PM
Temas de la conferencia
For decades, RAS proteins have been considered “undruggable.” This all changed following the recent approval of the first-ever targeted KRAS G12C therapy, marking a major landmark for this community. This breakthrough has certainly laid out a roadmap for future success, with more investment and innovation in the field than ever before, particularly within emerging discovery strategies being pursued by the biopharma industry.
Organizador profesional (PCO)
Hanson Wade

Información e inscripción:
Ms. Georgina FitzGerald
Medicina General
Cuota del Congreso
USD 1899.00 - USD 3796.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom